CoChat

Multi-cell type human liver microtissues for hepatotoxicity testing

Open access
Messner, S., Agarkova, I., Moritz, W., Kelm, J. M. · 2013 · Archives of Toxicology

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Current 2-dimensional hepatic model systems often fail to predict chemically induced hepatotoxicity due to the loss of a hepatocyte-specific phenotype in culture. For more predictive in vitro models, hepatocytes have to be maintained in a 3-dimensional environment that allows for polarization and cell-cell contacts. Preferably, the model will reflect an in vivo-like multi-cell type environment necessary for liver-like responses. Here, we report the characterization of a multi-cell type microtissue model, generated from primary human hepatocytes and liver-derived non-parenchymal cells. Liver microtissues were stable and functional for 5 weeks in culture enabling, for example, long-term toxicity testing of acetaminophen and diclofenac. In addition, Kupffer cells were responsive to inflammatory stimuli such as LPS demonstrating the possibility to detect inflammation-mediated toxicity as exemplified by the drug trovafloxacin. Herewith, we present a novel 3D liver model for routine testing in 96-well format capable of reducing the risk of unwanted toxic effects in the clinic.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00204-012-0968-2

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Liver microtissue production and culture. a Liver microtissues were produced in a 96-well hanging-drop culture platform (Gravity PLUS™). After microtissue formation, they were transferred into a microtissue-specific 96-well culture and assay platform (Gravity TRAP™). Further maintenance and compound treatments were performed in Gravity TRAP™ plates (3D Insight™ Human Liver Microtissues). b Bright field microscopy of a human liver microtissue. c Bright field microscopy of pooled human liver microtissues. d Size profiling of human liver hepatospheres shown in (c) [253 ± 7.4 μm in diameter (n = 14)]
Fig. 1 Liver microtissue production and culture. a Liver microtissues were produced in a 96-well hanging-drop culture platform (Gravity PLUS™). After microtissue formation, they were transferred into a microtissue-specific 96-well culture and assay platform (Gravity TRAP™). Further maintenance and compound treatments were performed in Gravity TRAP™ plates (3D Insight™ Human Liver Microtissues). b Bright field microscopy of a human liver microtissue. c Bright field microscopy of pooled human liver microtissues. d Size profiling of human liver hepatospheres shown in (c) [253 ± 7.4 μm in diameter (n = 14)]CC BY · PubMed Central
Fig. 2 Morphological characterization of liver microtissues. a Immunohistochemistry (IHC) staining for CK8 (epithelial cell marker). b IHC staining for CD68 (Kupffer macrophage marker). c IHC staining for CD31 (endothelial cell marker). d Periodic acid schiff staining (PAS) indicates distributed glycogen storage within hepatosphere. e IHC staining for multidrug resistance protein 1 (MDR1) indicates polarized expression of MDR1 on hepatocyte membranes, suggesting the formation of bile canaliculi. f IHC staining for bile salt export pump (BSEP) verifying bile canaliculi formation within hepatosphere
Fig. 2 Morphological characterization of liver microtissues. a Immunohistochemistry (IHC) staining for CK8 (epithelial cell marker). b IHC staining for CD68 (Kupffer macrophage marker). c IHC staining for CD31 (endothelial cell marker). d Periodic acid schiff staining (PAS) indicates distributed glycogen storage within hepatosphere. e IHC staining for multidrug resistance protein 1 (MDR1) indicates polarized expression of MDR1 on hepatocyte membranes, suggesting the formation of bile canaliculi. f IHC staining for bile salt export pump (BSEP) verifying bile canaliculi formation within hepatosphereCC BY · PubMed Central
Fig. 3 Hepatosphere viability and functionality over 5 weeks in culture. a Intra-tissue ATP quantification. ATP content per microtissue is depicted (pmol ATP/MT) as an indicator of cell viability and vitality. b Quantification of secreted albumin by ELISA over time, normalized to the initial hepatocyte cell number and time
Fig. 3 Hepatosphere viability and functionality over 5 weeks in culture. a Intra-tissue ATP quantification. ATP content per microtissue is depicted (pmol ATP/MT) as an indicator of cell viability and vitality. b Quantification of secreted albumin by ELISA over time, normalized to the initial hepatocyte cell number and timeCC BY · PubMed Central
Fig. 4 Long-term toxicity and inflammation-mediated toxicity testing with human liver microtissues using intra-tissue ATP as endpoint measurement. a Dose–response of acetaminophen toxicity after 14 days treatment (3 re-dosing) resulted in an IC50 value of 754.2 μM. b Dose–response curve of diclofenac supplemented for 14 days (3 re-dosing) resulted in an IC50 value of 178.6 μM. c Quantification of IL-6 secretion with ELISA measurement. Hepatosphere was induced for 48 h with 10 μg/ml LPS. Induction with LPS let to a tenfold increase in IL-6 secretion. d Dose–response of trovafloxacin induced toxicity in presence and absence of LPS. Presence of LPS decreased the IC50 threefold from 220 (-LPS) to 71 μM (+LPS)
Fig. 4 Long-term toxicity and inflammation-mediated toxicity testing with human liver microtissues using intra-tissue ATP as endpoint measurement. a Dose–response of acetaminophen toxicity after 14 days treatment (3 re-dosing) resulted in an IC50 value of 754.2 μM. b Dose–response curve of diclofenac supplemented for 14 days (3 re-dosing) resulted in an IC50 value of 178.6 μM. c Quantification of IL-6 secretion with ELISA measurement. Hepatosphere was induced for 48 h with 10 μg/ml LPS. Induction with LPS let to a tenfold increase in IL-6 secretion. d Dose–response of trovafloxacin induced toxicity in presence and absence of LPS. Presence of LPS decreased the IC50 threefold from 220 (-LPS) to 71 μM (+LPS)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 319

Metadata

Authors
Messner, S., Agarkova, I., Moritz, W., & Kelm, J. M.
Corresponding author
Kelm, J. M.
Venue
Archives of Toxicology
Published
2012-11-11
Volume
87
Issue
1
Pages
209-213
ISSN
  • 0340-5761 (ISSN-L)
  • 1432-0738
OpenAlex
W2079277029
Cited by
319
References
12
Citations by year
2026: 6 · 2025: 19 · 2024: 17 · 2023: 13 · 2022: 17 · 2021: 32 · 2020: 30 · 2019: 26 · 2018: 29 · 2017: 29 · 2016: 44 · 2015: 24 · 2014: 26 · 2013: 6 · 2012: 1
FWCI
20.61
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Archives of Toxicology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
European Commission (296257)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
Keywords
hepatotoxicity testing, 3D liver model, human hepatocytes, non-parenchymal liver cells, Kupffer cells, acetaminophen toxicity, trovafloxacin, lipopolysaccharide, 96-well format, in vitro toxicity prediction
MeSH terms
Humans, Kupffer Cells, Lipopolysaccharides, Naphthyridines, Toxicity Tests, Hepatocytes, Fluoroquinolones, Tissue Culture Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.